Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients

Overview of attention for article published in Leukemia, January 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 14,896 followers.

Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large… https://t.co/b9BHasqV8o

Soluble PDL1 as a prognostic biomarker for OS in diffuse large B-cell #lymphoma... - PubMed - NCBI https://t.co/b3LC0CSiPh

Soluble PDL1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell #lymphoma #lymsm https://t.co/8DIT8J1jnO

Our study of soluble PD-L1 and outcome in DLBCL now online in @LeukemiaJnl https://t.co/LS7CKY3duk #lymsm #lymphoma

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.